Cagrilintide and Ipamorelin Interaction

Synergistic
Mechanism-based 51% confidence

Cagrilintide and Ipamorelin have a synergistic interaction with 51% confidence. Cagrilintide helps counteract the insulin-disrupting effects of Ipamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects. Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

Cagrilintide

Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes

Subcutaneous injection enables optimal bioavailability, targeting dual amylin and calcitonin receptors for satiety and metabolic regulation. Enhances insulin sensitivity and controls gastric emptying.

Half-life: ~7 days (159-195 hours) Typical dose: 2.4mg weekly (after escalation) weight loss, metabolic
amylin receptor cardiotoxicinsulin sensitizing
View full profile

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low
Brain
low
Pituitary
low

Frequently Asked Questions

Can I take Cagrilintide with Ipamorelin?

Yes, Cagrilintide and Ipamorelin can generally be taken together. Cagrilintide helps counteract the insulin-disrupting effects of Ipamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects.

Is Cagrilintide and Ipamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between Cagrilintide and Ipamorelin?

Cagrilintide helps counteract the insulin-disrupting effects of Ipamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time Cagrilintide and Ipamorelin?

Cagrilintide has a half-life of ~7 days (159-195 hours) and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Cagrilintide vs Ipamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.